Search Results
Search for other papers by Sung Gwe Ahn in
Google Scholar
PubMed
Search for other papers by Chang Ik Yoon in
Google Scholar
PubMed
Search for other papers by Jae Hoon Lee in
Google Scholar
PubMed
Search for other papers by Hye Sun Lee in
Google Scholar
PubMed
Search for other papers by So Eun Park in
Google Scholar
PubMed
Search for other papers by Yoon Jin Cha in
Google Scholar
PubMed
Search for other papers by Chihwan Cha in
Google Scholar
PubMed
Search for other papers by Soong June Bae in
Google Scholar
PubMed
Search for other papers by Kyung-A Lee in
Google Scholar
PubMed
Search for other papers by Joon Jeong in
Google Scholar
PubMed
-positive/HER2-negative tumors, similar to high Ki67 level or poor histologic grade. Our findings are in line with those of previous studies indicating that the loss of PR expression correlates with aggressive tumor characteristics ( Arpino et al . 2005
Search for other papers by Wen G Jiang in
Google Scholar
PubMed
Search for other papers by Gareth Watkins in
Google Scholar
PubMed
Search for other papers by Oystein Fodstad in
Google Scholar
PubMed
Search for other papers by Anthony Douglas-Jones in
Google Scholar
PubMed
Search for other papers by Kefah Mokbel in
Google Scholar
PubMed
Search for other papers by Robert E Mansel in
Google Scholar
PubMed
from our study concurs with a previous study by Xie et al. (2001 a ) on breast cancer in that Cyr61 is raised in breast tumours and is associated with aggressiveness of the tumours, including higher levels in NPI-3, nodal status, high grade, TNM-3
Search for other papers by Fritz-Line Vélayoudom-Céphise in
Google Scholar
PubMed
Search for other papers by Pierre Duvillard in
Google Scholar
PubMed
Search for other papers by Lydia Foucan in
Google Scholar
PubMed
Search for other papers by Julien Hadoux in
Google Scholar
PubMed
Search for other papers by Cecile N Chougnet in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by David Malka in
Google Scholar
PubMed
Departments of Nuclear Medicine and Endocrine Oncology, Pathology, Department of Biostatistics and Epidemiology, Departments of Gastroenterology, Thoracic Oncology, Digestive Surgery, Medical Imaging, Faculté de Médecine Paris Sud, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
Search for other papers by Joël Guigay in
Google Scholar
PubMed
Search for other papers by Diane Goere in
Google Scholar
PubMed
Search for other papers by Thierry Debaere in
Google Scholar
PubMed
Search for other papers by Caroline Caramella in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Departments of Nuclear Medicine and Endocrine Oncology, Pathology, Department of Biostatistics and Epidemiology, Departments of Gastroenterology, Thoracic Oncology, Digestive Surgery, Medical Imaging, Faculté de Médecine Paris Sud, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
Search for other papers by David Planchard in
Google Scholar
PubMed
Search for other papers by Dominique Elias in
Google Scholar
PubMed
Departments of Nuclear Medicine and Endocrine Oncology, Pathology, Department of Biostatistics and Epidemiology, Departments of Gastroenterology, Thoracic Oncology, Digestive Surgery, Medical Imaging, Faculté de Médecine Paris Sud, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
Search for other papers by Michel Ducreux in
Google Scholar
PubMed
Search for other papers by Jean-Yves Scoazec in
Google Scholar
PubMed
Search for other papers by Eric Baudin in
Google Scholar
PubMed
but differs on some points. The most important differences are as follows: i) the use of only mitotic index and not Ki67 index for lung tumor grading and ii) a lower cutoff between low-grade and high-grade lung tumors, established at ten mitoses per 10
Search for other papers by Claudio Zamagni in
Google Scholar
PubMed
Search for other papers by Ralph M Wirtz in
Google Scholar
PubMed
Search for other papers by Pierandrea De Iaco in
Google Scholar
PubMed
Search for other papers by Marta Rosati in
Google Scholar
PubMed
Search for other papers by Elke Veltrup in
Google Scholar
PubMed
Search for other papers by Federica Rosati in
Google Scholar
PubMed
Search for other papers by Elisa Capizzi in
Google Scholar
PubMed
Search for other papers by Nicoletta Cacciari in
Google Scholar
PubMed
Search for other papers by Carlo Alboni in
Google Scholar
PubMed
Search for other papers by Alessandra Bernardi in
Google Scholar
PubMed
Search for other papers by Francesco Massari in
Google Scholar
PubMed
Search for other papers by Sara Quercia in
Google Scholar
PubMed
Search for other papers by Antonietta D'Errico Grigioni in
Google Scholar
PubMed
Search for other papers by Manfred Dietel in
Google Scholar
PubMed
Search for other papers by Jalid Sehouli in
Google Scholar
PubMed
Search for other papers by Carsten Denkert in
Google Scholar
PubMed
Search for other papers by Andrea Angelo Martoni in
Google Scholar
PubMed
with tumour grade and with the proliferation markers MKI67 and TOP2A in the available datasets of 35 patients. Spearman's correlation of the pretreatment gene expression levels and histological grade revealed a high positive correlation of grading with
Search for other papers by Nitya Raj in
Google Scholar
PubMed
Search for other papers by Youyun Zheng in
Google Scholar
PubMed
Search for other papers by Haley Hauser in
Google Scholar
PubMed
Search for other papers by Joanne Chou in
Google Scholar
PubMed
Search for other papers by Johnathan Rafailov in
Google Scholar
PubMed
Search for other papers by Jad Bou-Ayache in
Google Scholar
PubMed
Search for other papers by Peter Sawan in
Google Scholar
PubMed
Search for other papers by Jamie Chaft in
Google Scholar
PubMed
Search for other papers by Jennifer Chan in
Google Scholar
PubMed
Search for other papers by Kimberly Perez in
Google Scholar
PubMed
Search for other papers by Charles Rudin in
Google Scholar
PubMed
Search for other papers by Laura Tang in
Google Scholar
PubMed
Search for other papers by Diane Reidy-Lagunes in
Google Scholar
PubMed
performed. Pathology review of this post-treatment hepatic tumor specimen demonstrated well differentiated, now high grade (Ki-67 25%) disease and NGS identified a new alteration along the mTOR pathway in regulatory associated protein of mTOR gene ( RPTOR
Search for other papers by Sara Ekeblad in
Google Scholar
PubMed
Search for other papers by Bengt Nilsson in
Google Scholar
PubMed
Search for other papers by Margareta Halin Lejonklou in
Google Scholar
PubMed
Search for other papers by Térèse Johansson in
Google Scholar
PubMed
Search for other papers by Peter Stålberg in
Google Scholar
PubMed
Search for other papers by Ola Nilsson in
Google Scholar
PubMed
Search for other papers by Håkan Ahlman in
Google Scholar
PubMed
Search for other papers by Britt Skogseid in
Google Scholar
PubMed
, epithelioid, and mixed), mitotic rate (mitoses per high power field, assessed in 50 high power fields), and Ki67 index. Furthermore, the tumors were graded as having a very low ( n =0), low ( n =2), intermediate ( n =3), or high risk ( n =17) of malignant
Search for other papers by Wiebke Werner in
Google Scholar
PubMed
Search for other papers by Katharina Detjen in
Google Scholar
PubMed
Search for other papers by Alix Bruneau in
Google Scholar
PubMed
Search for other papers by Isabella Lurje in
Google Scholar
PubMed
Search for other papers by Natalie Nestel in
Google Scholar
PubMed
Search for other papers by Henning Jann in
Google Scholar
PubMed
Search for other papers by Frank Tacke in
Google Scholar
PubMed
Search for other papers by Bertram Wiedenmann in
Google Scholar
PubMed
Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine, University Düsseldorf, Düsseldorf, Germany
Search for other papers by Christoph Roderburg in
Google Scholar
PubMed
Search for other papers by Linda Hammerich in
Google Scholar
PubMed
analyses also revealed a significant survival benefit for patients with high overall CD3+ T cells ( Fig. 2C ) and CTL ( Fig. 2D ). Of note, general risk factors, for example, tumor grade or tumor stage, did not predict survival in our patient cohort
University College London Cancer Institute, Neuroendocrine Tumour Unit, Paul O'Gorman Building, Huntley Street, London WC1E 6BT, UK
Search for other papers by Anna Karpathakis in
Google Scholar
PubMed
Search for other papers by Martyn Caplin in
Google Scholar
PubMed
University College London Cancer Institute, Neuroendocrine Tumour Unit, Paul O'Gorman Building, Huntley Street, London WC1E 6BT, UK
Search for other papers by Christina Thirlwell in
Google Scholar
PubMed
the USA; however, both the classification systems are centred around the primary site of the tumour and histological grade. In Europe, the Ki-67 proliferative index is used to differentiate tumours of low (<2%), intermediate (2–20%) and high (>20
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Tisch Cancer Institute at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Search for other papers by Emily J Gallagher in
Google Scholar
PubMed
Search for other papers by Giampaolo Greco in
Google Scholar
PubMed
Search for other papers by Sylvia Lin in
Google Scholar
PubMed
Search for other papers by Radhi Yagnik in
Google Scholar
PubMed
Search for other papers by Sheldon M Feldman in
Google Scholar
PubMed
Search for other papers by Elisa Port in
Google Scholar
PubMed
Search for other papers by Neil B Friedman in
Google Scholar
PubMed
Search for other papers by Susan K Boolbol in
Google Scholar
PubMed
Search for other papers by Brigid Killelea in
Google Scholar
PubMed
Search for other papers by Melissa Pilewskie in
Google Scholar
PubMed
Search for other papers by Lydia Choi in
Google Scholar
PubMed
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Tisch Cancer Institute at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Search for other papers by Derek LeRoith in
Google Scholar
PubMed
Tisch Cancer Institute at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Department of Population Health Science and Policy, Center for Health Equity and Community Engaged Research, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Search for other papers by Nina A Bickell in
Google Scholar
PubMed
+) was defined clinically by immunohistochemistry or fluorescent in situ hybridization. BCs were defined as HR+/HER2–, HR+/HER2+, HR–/HER2+, and TNBC (HR–/HER2–) ( Howlader et al. 2014 ). Tumor grade was defined by the Nottingham combined histological
Search for other papers by S Felder in
Google Scholar
PubMed
Search for other papers by H Jann in
Google Scholar
PubMed
Search for other papers by R Arsenic in
Google Scholar
PubMed
Search for other papers by T Denecke in
Google Scholar
PubMed
Klinik für Nuklearmedizin, Universitätklinikum Ulm, Ulm, Germany
Search for other papers by V Prasad in
Google Scholar
PubMed
Search for other papers by B Knappe-Drzikova in
Google Scholar
PubMed
Innere Medizin und Gastroenterologie, Asklepios Klinik St. Georg, Asklepios Medical School, Hamburg, Germany
Search for other papers by S Maasberg in
Google Scholar
PubMed
Search for other papers by B Wiedenmann in
Google Scholar
PubMed
Medizinische Klinik 1, Gastroenterologie, Pneumologie und Endokrinologie, Universitätsklinikum der Friedrich-Alexander Universität Erlangen, Erlangen, Germany
Search for other papers by M Pavel in
Google Scholar
PubMed
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Uinversitätsklinikum Münster, Münster, Germany
Search for other papers by A Pascher in
Google Scholar
PubMed
Innere Medizin und Gastroenterologie, Asklepios Klinik St. Georg, Asklepios Medical School, Hamburg, Germany
Search for other papers by U F Pape in
Google Scholar
PubMed
association ( Soto-Solis et al. 2019 ). Others proposed four subtypes by differentiating the sporadic gNEN-3 subgroup according to the Ki-67-labelling index-based grading in gNET-3 and gNEC-4 ( Klöppel et al. 2007 ); because of supposed clinical